NFA
ALNY icon

Nationwide Fund Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Nationwide Fund Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,964
Closed -$936K – 88
2017
Q3 		$936K Sell
7,964
-3,233
-29% -$276K ﹤0.01% 1836
2017
Q2 		$893K Sell
11,197
-386
-3% -$24.7K ﹤0.01% 1847
2017
Q1 		$594K Buy
11,583
+2,707
+30% +$125K ﹤0.01% 2063
2016
Q4 		$332K Sell
8,876
-36,663
-81% -$1.54M ﹤0.01% 2384
2016
Q3 		$3.09M Sell
45,539
-500
-1% -$35.3K 0.01% 1194
2016
Q2 		$2.56M Sell
46,039
-7,436
-14% -$468K 0.01% 1250
2016
Q1 		$3.36M Sell
53,475
-3,033
-5% -$202K 0.01% 1121
2015
Q4 		$5.32M Buy
56,508
+8,742
+18% +$811K 0.02% 885
2015
Q3 		$3.84M Sell
47,766
-3,088
-6% -$343K 0.02% 1053
2015
Q2 		$6.1M Sell
50,854
-14,370
-22% -$1.72M 0.03% 864
2015
Q1 		$6.81M Sell
65,224
-6,031
-8% -$611K 0.03% 820
2014
Q4 		$6.91M Sell
71,255
-12,610
-15% -$1.17M 0.03% 763
2014
Q3 		$6.55M Sell
83,865
-1,860
-2% -$120K 0.03% 795
2014
Q2 		$5.42M Sell
85,725
-44,275
-34% -$2.63M 0.02% 935
2014
Q1 		$8.73M Sell
130,000
-3,450
-3% -$267K 0.04% 570
2013
Q4 		$8.59M Buy
133,450
+3,913
+3% +$233K 0.04% 651
2013
Q3 		$8.29M Sell
129,537
-3,663
-3% -$183K 0.04% 623
2013
Q2 		$4.13M Buy
+133,200
New +$3.54M 0.02% 903

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM

Nationwide Fund Advisors's ALNY Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2017, closing a stake of 7,964 shares — an estimated $936K sold.

Nationwide Fund Advisors first reported a position in ALNY in Q2 2013 and held it in 18 quarters. The position peaked at $8.73M in Q1 2014. 282 funds tracked by Wall St. Rank hold ALNY as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Alnylam Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7,964 Alnylam Pharmaceuticals shares in Q4 2017, an estimated $936K.
  • Nationwide Fund Advisors first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Alnylam Pharmaceuticals position peaked at $8.73M in Q1 2014.
  • 282 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.